Stories by Rob Stein

Rob Stein

Rob Stein

Correspondent and Senior Editor, Science Desk

The FDA gives the green light to the first gene therapy for deafness
By Rob Stein

The FDA gives the green light to the first gene therapy for deafness

Rob Stein | Apr 23, 2026, 8:46 PM UTC
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.
Gene therapy for a rare type of deafness shows lasting results
By Rob Stein
Gene therapy for a rare type of deafness shows lasting results
Rob Stein | Apr 22, 2026, 3:00 PM UTC